Blog

Cloudflare's (NYSE: NET) stock hit an all-time high of $221.64 last November. But over the past two months, it plunged nearly 50% as interest rate fears overshadowed the company's impressive growth

The Roth IRA (individual retirement account) is a one-of-a-kind retirement goodie that's too good to pass up, especially if you think you'll be in a higher tax bracket later.

It's a way to set

While the internet is an ever-changing and ever-expanding entity, one component of it will always remain the same -- the demand for advertising. The Trade Desk (NASDAQ: TTD) empowers buyers of

Most of the time, most investors' focus should be on the long term That's not to say, however, that long-term investors should simply ignore any and all real-time developments. Important long-term

So you want to amass a million dollars by retirement, and you'd like to get there by investing in an exchange-traded fund (ETF) -- a fund that trades like a stock. That's a fine plan (though some

Vaccine giant Moderna (NASDAQ: MRNA) has gained a jaw-dropping 1,200% over the past two years. That's after the biotech company developed a coronavirus vaccine and brought it to market in about nine

For many investors, taking a long-term buy-and-hold strategy for dozens of stocks is the best choice. This strategy has certainly paid off in the past: If you bought $10,000 in Alphabet (NASDAQ:

What does the most valuable player of the NFL's championship game say to the camera after winning? Where he's going next -- to Disney World.

If the cryptocurrency world had a championship most

"Best" is in many cases a really subjective term. That's certainly true when it comes to stocks. The ones that one person considers the best could be completely different from another individual's

The start of a new year is an opportune time for investors to evaluate their retirement savings strategy and make updates if necessary. Making the most of your retirement contributions today will

You'll often hear that signing up for Social Security at 62 is a bad idea. The reason? It will result in a lower monthly benefit for the rest of your retirement.

You're eligible to receive your full

Salesforce.com (NYSE: CRM) stock fell 10.8% following a disappointing earnings announcement on Nov. 30. While the company outpaced Wall Street estimates for revenue and earnings, analysts were

C3.ai (NYSE: AI) shares fell 15.4% in December following a disappointing earnings announcement. The company reported quarterly results on Dec. 1 and beat Wall Street's estimates for both sales and

Shares of diagnostic testing company Fulgent Genetics (NASDAQ: FLGT) were up 93% last year, according to S&P Global Market Intelligence. The unpredictability of COVID took shareholders on a journey

Shares of virtual healthcare provider Teladoc Health (NYSE: TDOC) fell 54% last year, according to data provided by S&P Global Market Intelligence. The performance is especially painful in a year in

Shares of Bill.com Holdings (NYSE: BILL) dropped 11% in December by no fault of their own. The company didn't have any major news last month, but its stock was another victim of investors bailing

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Was last week —

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

One of the

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Remember the

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose 16.4% last month as investors favored healthcare stocks and other defensive industries. There wasn't any major news about Walgreens in December

Failing to recover from its 7.6% decline in November, shares of SolarEdge Technologies (NASDAQ: SEDG) plunged 14.4% in the last month of 2021, according to data from S&P Global Market Intelligence.

Biotech stocks haven't been at their best of late. The SPDR S&P Biotech Exchange Traded Fund (NYSEMKT: XBI) has lost more than 30% of its value over the prior 12 months. The XBI is thus bumping up

2021 was a rough year for many manufacturers, as businesses were forced to navigate cost increases and supply chain constraints. Electric-vehicle (EV) leader Tesla (NASDAQ: TSLA) handled those

Sherwin-Williams (NYSE: SHW), the world's largest paint and coatings company, saw its shares rise 43% in 2021, according to data from S&P Global Market Intelligence. The stock began 2020 at $245 a

Particularly during President Trump's administration, conservatives charged Big Tech with conspiring to silence their voices by either changing their algorithms to shadow ban them or outright